Product Program year 2020 Source: CMS Open Payments

Atellica

Device DX - Diagnostics incl. all products and services

Open in the dashboard

General payments

$42,562

169 payments

Research payments

$411,224

21 payments

Through program year 2020, $42,562 in general payments and $411,224 in research payments were reported against Atellica (DX - Diagnostics incl. all products and services).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $27,742 51
2020 Research $243,849 9
2019 General $14,820 118
2019 Research $167,376 12

Breakdown

Who paid General payments · program years 2019–2020
  1. Siemens Medical Solutions USA, Inc. $42,562 169 payments
Top recipients General payments · program year 2020
  1. University Medical Center Teaching hospital · NV $9,000 32% · 4 payments
  2. Childrens Hospital Medical Center Teaching hospital · OH $7,000 25% · 5 payments
  3. Christian Nasr Endocrinology, Diabetes & Metabolism · Cleveland, OH $4,969 18% · 1 payment
  4. Marius Stan Endocrinology, Diabetes & Metabolism · Rochester, MN $2,613 9% · 1 payment
  5. Swedish Covenant Health Teaching hospital · IL $2,000 7% · 1 payment

The top 5 of 39 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $7,581 78% · 2 practitioners
  2. Gastroenterology Internal Medicine $804 8% · 1 practitioner
  3. Infectious Disease Internal Medicine $775 8% · 1 practitioner
  4. Anatomic Pathology & Clinical Pathology Pathology $389 4% · 23 practitioners
  5. Anatomic Pathology Pathology $72 <1% · 1 practitioner

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Ohio $12,744 46% · 3 recipients
  2. Nevada $9,000 32% · 1 recipient
  3. Minnesota $2,613 9% · 1 recipient
  4. Illinois $2,017 7% · 2 recipients
  5. Virginia $804 3% · 1 recipient

The top 5 of 19 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

169 general · 21 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record